Author Question: Dr. Mottle's experiment includes randomizing subjects to a group that gets a needle -stick or to a ... (Read 91 times)

sc00by25

  • Hero Member
  • *****
  • Posts: 596
Dr. Mottle's experiment includes randomizing subjects to a group that gets a needle -stick or to a group that gets a fake needle-stick.
 
   Differentiate experimental group from control group.
 
  What is the role of the placebo in experimental design? Give another example of use of a placebo.
  What will be an ideal response?

Question 2

Which of the following illustrates reliability?
 
  a. Dean takes an IQ test and scores at the 60th percentile.
  b. Scores on a new test of reading comprehension correlate highly with scores on well established reading comprehension tests.
  c. Fred scores poorly on one school's entrance exam but does better on another.
   d. Jacquie takes three practice GRE verbal exams and scores 300, 299, and 301 .



manuelcastillo

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

Experimental group receives the active intervention, the control group receives no intervention or an inactive intervention such as a placebo. A placebo is an inactive substitute for a true intervention. It is sometimes called a sugar pill, but can be something other than a pill. For example a researcher could use a fake camera for a
placebo and a real camera in the experimental group.

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library